(Q34034405)

30 July 2017

1 reference

title

Osteoporosis. Pathogenesis, diagnosis, and treatment in older adults (English)

1 reference

30 July 2017

0 references

0 references

Kenny AM

1

1 reference

30 July 2017

Prestwood KM

series ordinal

2

1 reference

30 July 2017

language of work or name

1 reference

1 August 2000

1 reference

Rheumatic Diseases Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

26

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

569-591

1 reference

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Risk factors for increased bone loss in an elderly population: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Growth factors and the regulation of bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Can we improve compliance with long-term HRT?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Estrogen Protection against Bone Resorbing Effects of Parathyroid Hormone Infusion: Assessment by Use of Biochemical Markers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Epidemiology of osteoporosis and osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Osteoporosis in men with idiopathic hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Osteopenia in Men with a History of Delayed Puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Differences in the time course of the effects of oophorectomy in women on parameters of bone metabolism and interleukin-1 levels in the circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Lifetime leisure exercise and osteoporosis. The Rancho Bernardo study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Femoral bone loss progresses with age: a longitudinal study in women over age 65.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Bone mineral density in elderly men and women: results from the Framingham osteoporosis study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

An 18-year prospective study of dietary calcium and bone mineral density in the hip.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Cytokines and estrogen in bone: anti-osteoporotic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Testosterone deficiency as a risk factor for hip fractures in men: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Life-style and different fracture prevalence: a cross-sectional comparative population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Dietary calcium, sex hormones, and bone mineral density in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Serum insulin-like growth factor binding protein profiles in postmenopausal women: their correlation with bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Bisphosphonate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Association of osteoporotic vertebral compression fractures with impaired functional status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Analgesic effect of Salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Bone density and fracture risk in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Bone loss in elderly women prevented by ultralow doses of parenteral 17β-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Assessment of sex hormones and bone mineral density in relation to occurrence of fracture in men: a prospective population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Exercise and other factors in the prevention of hip fracture: the Leisure World study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

1 reference

7 January 2021

Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of calcium supplementation on bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The worldwide problem of osteoporosis: insights afforded by epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Risk factors for spinal osteoporosis in men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

1 reference

7 January 2021

Long-Term Bone Loss in Men: Effects of Genetic and Environmental Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Esophageal ulceration due to alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970157-5

7 January 2021

10.1016/S0889-857X(05)70157-5

Identifiers

DOI

1 reference

30 July 2017

1 reference